Patents by Inventor Martin Andreas Picard

Martin Andreas Picard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTINUOUS ADMINISTRATION OF CILENGITIDE IN CANCER TREATMENTS
    Publication number: 20120130146
    Abstract: The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising the continuous administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agent or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy.
    Type: Application
    Filed: May 25, 2010
    Publication date: May 24, 2012
    Applicant: Merck Patent GmbH
    Inventors: Martin Andreas Picard, Ullrich Bethe, Matthias Dotzauer, Elizabeth Cohen-Jonathan Moyal
  • THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER
    Publication number: 20110230423
    Abstract: The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agents or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy. The therapy results in a synergistic potential increase of the inhibition effect of each individual therapeutic on tumor cell proliferation, yielding more effective treatment than found by administering an individual component alone, concurrently or not in the dosage regime of the present invention.
    Type: Application
    Filed: November 13, 2009
    Publication date: September 22, 2011
    Inventors: Martin Andreas Picard, Christian Manegolo, Helen Wheeler, Mustafa Khasraw, Bart Neyns
  • SPECIFIC THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER
    Publication number: 20100069302
    Abstract: The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agents or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy. The therapy results in a synergistic potential increase of the inhibition effect of each individual therapeutic on tumor cell proliferation, yielding more effective treatment than found by administering an individual component alone, concurrently or not in the dosage regime of the present invention.
    Type: Application
    Filed: January 17, 2008
    Publication date: March 18, 2010
    Inventors: Stefan Krueger, Simon Goodman, Andreas Harastrick, Martin Andreas Picard, Johannes Nippgen, Ulrike Grimm, Roger Stupp, Michael Weller
  • Specific therapy using integrin ligands for treating cancer
    Publication number: 20090130098
    Abstract: The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agents or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy. The therapy results in a synergistic potential increase of the inhibition effect of each individual therapeutic on tumor cell proliferation, yielding more effective treatment than found by administering an individual component alone, concurrently or not in the dosage regime of the present invention.
    Type: Application
    Filed: January 18, 2007
    Publication date: May 21, 2009
    Applicant: Merck Patent GmbH
    Inventors: Simon Goodman, Martin Andreas Picard, Tom Mikkelsen, Johannes Nippgen, Ulrike Grimm, Roger Stupp, Michael Weller, Andreas Harstrick, Matthias Grell